Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

he 36-month results from Veryan Medical’s MIMICS-2 study for the BioMimics 3D femoropopliteal stent showed low rates of revascularization and compared very favorably to current standards of care. The results were presented by Professor Thomas Zeller, M.D., University Heart Centre Freiburg, Bad Krozingen, Germany at the CX 2020 Live conference.

News | Peripheral Artery Disease (PAD)

Excellent 3-year Results in MIMICS-2 Study of the BioMimics 3D Vascular Stent

June 16, 2020 — The 36-month results from Veryan Medical’s MIMICS-2 study for the BioMimics 3D femoropopliteal stent ...

June 16, 2020

News | EP Lab

Frequent Coffee Consumption Lowers Chance of Arrhythmias

May 28, 2020 – A recent study revealed that drinking a couple of cups of coffee per day does not lead to a greater risk ...

May 28, 2020

TCT cancels in-person meeting and goes virtual due to COVID-19

News | Cath Lab

TCT Cancels In-person Conference and Goes Virtual Due to COVID-19

May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, the C ...

May 27, 2020

Feature | Coronavirus (COVID-19)

WHO Database Shows Serious Health Impact of Hydroxychloroquine and Azithromycin Being Used to Treat COVID-19

May 27, 2020 — Two of the front-line drugs being used to treat COVID-19 (SARS-CoV-2) patients are hydroxychloroquine and ...

May 27, 2020

Videos | HRS

VIDEO: Top New EP Technologies at Heart Rhythm Society 2020

Interview with Andrew D. Krahn, M.D., FHRS, head of the division of cardiology at St. Paul’s Hospital, and professor of ...

May 22, 2020

Feature | SCAI

SCAI Announces 2020 Late-breaking Clinical Studies

May 21, 2020 — Here is the list of late-breaking study presentations and links to articles about each of them from the S ...

May 21, 2020

Left, the Melody pulmonary valve was the first transcatheter valve to be approved by the FDA in the United States a decade ago. Right, the Harmony transcatheter valve is in trials and is designed to treat patients with RVOT anomalies who develop severe PR typically when a pervious repair fails. Both valves are used to treat congenital heart defects. #SCAI #SCAI2020

News | Congenital Heart

Medtronic Congenital Heart Transcatheter Valve Studies Show Strong Results in SCAI Late-breakers

May 21, 2020 — Two late-breaking clinical trials on trans catheter valves to treat congenital heart disease were ...

May 21, 2020

Rash on the skin of a child who has COVID-19 related multi-system inflammatory syndrome (MIS-C). Image copyright Damien Bonnet, M.D., Ph.D., courtesy of the American Heart Association. Coronavirus is linked with this Kawasaki-like inflammatory disease in children. #MIS-C #COVID #COVIDinkids #COVIDinChildren

Feature | Coronavirus (COVID-19) | Dave Fornell, Editor

Kawasaki-like Inflammatory Disease Affects Children With COVID-19

A new, serious COVID-19 cardiovascular presentation emerged in late April and early May 2020 in the form of pediatric ...

May 20, 2020

PREDICT-AF trial showed first time there is extensive extracellular matrix remodeling. #HRS2020 #Heartrhythm2020. Marilyn Fornell

News | Atrial Fibrillation

Heart Tissue Changes Can Predict Atrial Fibrillation Prior to Onset

May 19, 2020 — Structural changes of the atrium may occur long before the onset of atrial fibrillation (AF), and the ...

May 19, 2020

Results of the Atrial Fibrosis Predicts Recurrent Stroke Or New Atrial Fibrillation In Patients With Embolic Stroke Of Undetermined Source - A Multi-Center Study at HRS 2020. #HRS2020 #Heartrhythm2020,

News | Atrial Fibrillation

Atrial Fibrosis Predicts Recurrent Stroke or New AF Onset

May 19, 2020 — Atrial disease has been implicated in embolic stroke of undetermined source (ESUS) and a late-breaking ...

May 19, 2020

Mayo Clinic is using artificial intelligence EchoGo Core software from Ultromics to automatically analyize echocardiography images to assess the cardiac impact of COVID-19. The AI software is from Ultromics.

News | Coronavirus (COVID-19)

Mayo Clinic Uses Artificial Intelligence to Help Assess Cardiac Danger From COVID-19

May 19, 2020 — A joint U.K.-U.S. research team is applying a pioneering artificial intelligence (AI) system to ...

May 19, 2020

Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020

Feature | Cath Lab

Eating Prior to Cardiac Cath Noninferior to Fasting in CHOW NOW Study

May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or ...

May 18, 2020

News | SCAI

ISCHEMIA Trial: Patients With Intermediate Left Main Coronary Disease Have Worse Cardiovascular Events

May 17, 2020 – A new study shows that when compared with patients without intermediate left main coronary artery disease ...

May 17, 2020

News

Stem Cell Therapy Improved Quality of Life in Patients with Microvascular Dysfunction

May 17, 2020 – Trial results presented today revealed a promising therapy for patients experiencing angina due to ...

May 17, 2020

Icosapent Ethyl (Vascepa) significantly Reduces Revascularizations in Statin Patients in the REDUCE-IT REVASC analyses presented as a late-breaking study at SCAI 2020. Photo by Dave Fornell

News | Pharmaceuticals

Icosapent Ethyl Significantly Reduces Revascularizations in Statin Patients

May 17, 2020 – Patients with high lipid levels have an increased risk for ischemic events, despite statin therapy ...

May 17, 2020